07.06.2013 11:05 Uhr, Quelle: Wallstreet online

ASCO 2013: New data on breast cancer prognosis tests - EndoPredict and uPA/PAI-1 compared

(DGAP-Media / 07.06.2013 / 11:00) Cologne/ Chicago - At the annual meeting of the «American Society of Clinical Oncology» (ASCO) in Chicago, new data from clinical practice on the breast cancer prognosis tests EndoPredict and uPA/PAI-1 were …

Weiterlesen bei Wallstreet online